Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hemorrhage × Dalteparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thromboembolism 10 Venous Thrombosis 7 Pulmonary Embolism 7 Neoplasms 6 Lung Neoplasms 3 Thrombosis 2 Thromboembolism 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Monoclonal Gammopathy of Undetermined Significance 1 Mesenteric Ischemia 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

Tranexamic Acid 6 Sodium Chloride 2 Ringer's Lactate 2 maleimide-polyethylene glycol-modified hemoglobin, MP4 1 bemiparin 1 Uterine Artery Embolization 1 Tourniquets 1 Sutures 1 Surgicel 1 Saline Solution 1 Rivaroxaban 1 Ringer's Solution 1 Pancreaticoduodenectomy 1 Mannitol 1 Lenalidomide 1 Ibuprofen 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Furosemide 1 FloSeal Matrix 1 Esomeprazole 1 Data Collection 1 Dalteparin 1 Crystalloid Solutions 1 Colloids 1 Blood Transfusion 1 Aspirin 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01741506 2015-06-23

COPPVATS

Aarhus University Hospital

Phase 4 Completed

Hemorrhage, Lung Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡